EphA3 is up-regulated by epidermal growth factor and promotes formation of glioblastoma cell aggregates

Biochem Biophys Res Commun. 2019 Jan 15;508(3):715-721. doi: 10.1016/j.bbrc.2018.12.002. Epub 2018 Dec 6.

Abstract

EphA3, a member of the Eph family of receptor tyrosine kinases, has been reported to be overexpressed in some human cancers including glioblastoma. Here, we found that expression of EphA3 is up-regulated in response to epidermal growth factor (EGF) stimulation and promotes formation of cell aggregates in suspension culture of glioblastoma cells. Suppression of EphA3 expression by short hairpin RNA-mediated knockdown or CRISPR/Cas9-mediated gene deletion inhibited EGF-induced promotion of cell aggregate formation, whereas overexpression of EphA3 promoted formation of cell aggregates in suspension culture. EGF-induced EphA3 expression and promotion of cell aggregate formation required Akt activity. Furthermore, N-cadherin, whose expression was regulated by EGF and EphA3, contributed to the formation of cell aggregates in suspension culture. These results suggest that the regulation of EphA3 expression plays a critical role in glioblastoma cell growth in non-adherent conditions.

Keywords: EGF; EphA3; Glioblastoma.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Brain Neoplasms / genetics*
  • Brain Neoplasms / pathology*
  • Cadherins / metabolism
  • Cell Aggregation / drug effects
  • Cell Line, Tumor
  • Epidermal Growth Factor / pharmacology*
  • Gene Expression Regulation, Neoplastic* / drug effects
  • Glioblastoma / genetics*
  • Glioblastoma / pathology*
  • Humans
  • Proto-Oncogene Proteins c-akt / metabolism
  • Receptor Protein-Tyrosine Kinases / genetics*
  • Receptor Protein-Tyrosine Kinases / metabolism
  • Receptor, EphA3
  • Suspensions
  • Up-Regulation / drug effects
  • Up-Regulation / genetics*

Substances

  • Cadherins
  • Suspensions
  • Epidermal Growth Factor
  • EPHA3 protein, human
  • Receptor Protein-Tyrosine Kinases
  • Receptor, EphA3
  • Proto-Oncogene Proteins c-akt